About 600 reports

Hepatitis A (Infectious Disease) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis A - Drugs In Development, 2021, provides an overview of the Hepatitis A (Infectious Disease) pipeline landscape.Hepatitis A is inflammation of the liver...

  • Hepatitis
  • Drug Development
  • World
  • China

China’s demand for Hepatitis Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...

  • Hepatitis
  • China
  • Industrial Production
  • Labour Force

Hepatitis C (Infectious Disease) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis C - Drugs In Development, 2021, provides an overview of the Hepatitis C (Infectious Disease) pipeline landscape. Hepatitis C is a contagious viral...

  • Hepatitis
  • Drug Development
  • World
  • United States
  • China
  • Pharmaceutical Registrations
  • Stem Cell Transplantation

Hepatitis D (Infectious Disease) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis D - Drugs In Development, 2021, provides an overview of the Hepatitis D (Infectious Disease) pipeline landscape. Hepatitis D, also known as the delta...

  • Hepatitis
  • Drug Development
  • World
  • Drug Approval
  • Pharmaceutical Registrations

Hepatitis Viruses Rapid Tests and POC - Medical Devices Pipeline Product Landscape, 2021 Summary Medical Devices sector report, “Hepatitis Viruses Rapid Tests and POC - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Hepatitis Viruses Rapid Tests...

  • Hepatitis
  • Diagnostics
  • Clinical Trial
  • Hepatitis Testing
  • World
  • Interest Payments Paid By Central Government
  • Medical Devices Sales

Hepatitis C Virus Envelope Protein E2 - Drugs in Development, 2021 Summary Hepatitis C Virus Envelope Protein E2 pipeline Target constitutes close to 10 molecules. Out of which approximately 4 molecules are developed by companies and remaining by the universities/institutes. The latest report Hepatitis...

  • Hepatitis
  • Drug Development
  • World

Hepatitis A - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis A - Pipeline Review, H2 2020, provides an overview of the Hepatitis A (Infectious Disease) pipeline landscape. Hepatitis A is inflammation of the liver caused by hepatitis...

  • Hepatitis
  • World
  • India
  • China
  • Drug Approval

Hepatitis B - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis B - Pipeline Review, H2 2020, provides an overview of the Hepatitis B (Infectious Disease) pipeline landscape. Hepatitis B is a potentially life-threatening liver infection...

  • Hepatitis
  • World
  • China
  • Pharmaceutical Registrations
  • Manufacturing Output

Hepatitis D - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis D - Pipeline Review, H2 2020, provides an overview of the Hepatitis D (Infectious Disease) pipeline landscape. Hepatitis D, also known as the delta virus, is an infection...

  • Hepatitis
  • World
  • Drug Approval
  • Dropout Rate

Hepatitis C - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis C - Pipeline Review, H2 2020, provides an overview of the Hepatitis C (Infectious Disease) pipeline landscape. Hepatitis C is a contagious viral infection affecting...

  • Hepatitis
  • United States
  • China
  • Drug Approval
  • Stem Cell Transplantation

Hepatitis C - Competitive Landscape in 2021 Summary Hepatitis C - Competitive Landscape in 2021 combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace. In hepatitis C, Nonstructural proteins 5A (NS5A)...

  • Hepatitis
  • World
  • Advertising Expenditure
  • Prescription Drug Sales

Hepatitis Viruses Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Hepatitis Viruses Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Hepatitis Viruses Rapid Tests & POC pipeline...

  • Hepatitis
  • Clinical Trial
  • World
  • South Africa
  • Direct Sales
  • Prescription Drug Sales

Hepatitis C Virus Envelope Protein E2 - Pipeline Review, H2 2020 Summary According to the recently published report ’Hepatitis C Virus Envelope Protein E2 - Pipeline Review, H2 2020’; Hepatitis C Virus Envelope Protein E2 pipeline Target constitutes close to 9 molecules. Out of which approximately...

  • Hepatitis
  • World

Hepatitis Therapeutics Market by Disease Type (Hepatitis B, Hepatitis C, Other Hepatitis), Drug Class (Oral Antivirals, and Immune Modulators), and Distribution Channel (Hospitals Pharmacies, Drug Stores & Retail Pharmacies, and Online Providers): Global Opportunity Analysis and Industry Forecast, 2021–2030 The global...

  • Hepatitis
  • World
  • APAC
  • Europe

Hepatitis Therapeutics market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Hepatitis Therapeutics Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Hepatitis Therapeutics types, applications. Further, Hepatitis...

  • Hepatitis
  • World

Hepatitis Diagnostic Test market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Hepatitis Diagnostic Test Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Hepatitis Diagnostic Test types, applications. Further,...

  • Diagnostics
  • Hepatitis
  • World

Hepatitis A - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis A - Pipeline Review, H1 2020, provides an overview of the Hepatitis A (Infectious Disease) pipeline landscape. Hepatitis A is inflammation of the liver caused by hepatitis...

  • Hepatitis
  • World
  • China
  • India
  • Drug Approval

Hepatitis B (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis B - Drugs In Development, 2021, provides an overview of the Hepatitis B (Infectious Disease) pipeline landscape.Hepatitis B is a potentially life-threatening...

  • Infectious Disease
  • Hepatitis
  • World

China’s demand for Blood Products has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...

  • Vaccine
  • Healthcare
  • Hepatitis
  • Protein Therapy
  • Clinical Chemistry
  • China
  • United States
  • Industrial Production
  • Labour Force

Hepatitis D - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis D - Pipeline Review, H1 2020, provides an overview of the Hepatitis D (Infectious Disease) pipeline landscape. Hepatitis D, also known as the delta virus, is an infection...

  • Hepatitis
  • World
  • Drug Approval
  • Dropout Rate

Abstract: - Global Hepatitis Therapeutics Market to Reach $25.8 Billion by 2027 - Amid the COVID-19 crisis, the global market for Hepatitis Therapeutics estimated at US$21.1 Billion in the year 2020, is projected to reach a revised size of US$25.8 Billion by 2027, growing at a CAGR of 2.9% over the analysis period...

  • Hepatitis
  • World
  • China
  • United States

Abstract: - Global Hepatitis B Vaccines Market to Reach $1.9 Billion by 2027 - Amid the COVID-19 crisis, the global market for Hepatitis B Vaccines estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$1.9 Billion by 2027, growing at aCAGR of 3.3% over the period 2020-2027. Mono Vaccines,...

  • Hepatitis
  • World
  • China
  • United States

Abstract: - Global Viral Hepatitis and Retrovirus Diagnostic Tests Market to Reach $5.9 Billion by 2027 - Amid the COVID-19 crisis, the global market for Viral Hepatitis and Retrovirus Diagnostic Tests estimated at US$3.3 Billion in the year 2020, is projected to reach a revised size of US$5.9 Billion by 2027, growing...

  • Hepatitis
  • HIV AIDS
  • Diagnostics
  • World
  • China
  • United States

Hepatitis Therapeutics Market Report Overview Hepatitis Therapeutics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Hepatitis Therapeutics market types and applications. It is a focused study on Hepatitis Therapeutics market space...

  • Hepatitis
  • World
  • Health Provider Density

Hepatitis Diagnostic Test Market Report Overview Hepatitis Diagnostic Test market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Hepatitis Diagnostic Test market types and applications. It is a focused study on Hepatitis Diagnostic Test market...

  • Diagnostics
  • Hepatitis
  • World
  • Health Provider Density

Hepatitis C - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis C - Pipeline Review, H1 2020, provides an overview of the Hepatitis C (Infectious Disease) pipeline landscape. Hepatitis C is a contagious viral infection affecting...

  • Hepatitis
  • China
  • Pharmaceutical Registrations
  • Prescription Drug Sales

Hepatitis C Virus Envelope Protein E2 - Pipeline Review, H1 2020 Summary Hepatitis C Virus Envelope Protein E2 pipeline Target constitutes close to 9 molecules. Out of which approximately 3 molecules are developed by companies and remaining by the universities/institutes. The latest report Hepatitis...

  • Hepatitis
  • World

Chronic Hepatitis B (CHB) - Epidemiology Forecast to 2029 Summary Hepatitis B is a liver disease caused by the hepatitis B virus (HBV).Hepatitis B is transmitted from person to person through blood, semen, and other body fluids (CDC, 2020; Mayo Clinic, 2020). Hepatitis B is a vaccine-preventable...

  • Hepatitis
  • World
  • Infectious Disease Prevalence
  • Vaccination Coverage

Hepatitis Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Hepatitis Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Hepatitis Tests pipeline products with comparative analysis of the products at various stages...

  • Hepatitis
  • Clinical Trial
  • World
  • Europe
  • Direct Sales
  • Prescription Drug Sales

Hepatitis Diagnostic Test Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Hepatitis Diagnostic Test market including the COVID-19 pandemic implications...

  • Diagnostics
  • Hepatitis
  • APAC
  • Central America